Biopharma M&A: You Ain’t Seen Nothing Yet

Barron's has previously discussed how mergers and acquisitions will be a theme for pharma and biotech. With Takeda Pharmaceutical’s (4502.Japan) deal to buy Shire (SHPG), Leerink's Geoffrey Porges takes a look at what other deals could come to fruition.